ArticleThe World Allergy Organization journal2026
Solitary chemosensory cells amplify eosinophilic inflammation via PAR-2 activation in house dust mite-sensitized allergic rhinitis.
Article in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recent studies have shown that solitary chemosensory cells (SCCs) are rare nasal epithelial cells effectively responding to pathogens and are the predominant epithelial sources of IL-25. We investigated the roles of SCCs in nasal eosinophilic inflammation in house dust mite (HDM)-sensitized allergic rhinitis (AR). Methods: Epithelial phenotypes were detected in nasal mucosal specimens from control participants and HDM-AR patients. Differentiated human nasal epithelial cells (hNECs) were exposed to HDM extract Results: POU2F3 Conclusions: These findings demonstrated that SCCs could sense HDM and produce IL-25, triggering mucin overproduction and eosinophilic IL-25 receptor expression via PAR-2 activation, which suggesting that SCCs might be powerful immunomodulators of nasal eosinophilic inflammation in HDM-AR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.